Market Analysis

Market Analysis Submit Abstract Register Now

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024.

  • Regenerative medicine research in World
  • Human Tissue Market in Asia
  • Tissue analysis products Market in USA
  • Stem cell analysis products Market in UK

Related Conference of Market Analysis

April 16-17, 2026

9th Annual Conference on Stem Cell and Regenerative Medicine

Tokyo, Japan
April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
May 04-05, 2026

14th World Congress on Human Genetics and Genetic Diseases

Paris, France
May 25-26, 2026

20th International Conference on Regenerative Repair and Medicine

Madrid, Spain
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

16th International Conference on Human Genetics and Genetic Diseases

Singapore City, Singapore
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 24-25, 2026

7th Annual summit on Cell Signaling and Cancer Therapy

Paris, France
September 24-25, 2026

19th World Congress on Advances in Stem Cell Research and Regenerative Medicine

Paris, France

Market Analysis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in